{"transactions":[{"id":1490813,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:08:45.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":266354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a one year period in equal quarterly installments."}],"balance_after":266354,"derivative":{"exercise_price":1.28,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":266354},"source":{"system":"sec-edgar","filing":"0001437749-24-019343","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924019343/rdgdoc.xml","form_type":"4"}},{"id":1756407,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-10-23T06:05:03.000Z","date":"2023-10-20","kind":"purchase","planned":false,"acquired":true,"shares":329342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person exercised vested Warrants (the \"Original Warrants\") to purchase 299,402 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 (\"Closing Date\").  The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants."}],"balance_after":329342,"derivative":{"exercise_price":0.95,"exercise_date":"2023-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":329342},"source":{"system":"sec-edgar","filing":"0001437749-23-028700","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923028700/rdgdoc.xml","form_type":"4"}},{"id":1756406,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-10-23T06:05:03.000Z","date":"2023-10-20","kind":"other","planned":false,"acquired":false,"shares":299402,"price":0.125,"value":37425.25,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.71,"exercise_date":"2023-04-20","expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":299402},"source":{"system":"sec-edgar","filing":"0001437749-23-028700","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923028700/rdgdoc.xml","form_type":"4"}},{"id":1756405,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-23T06:05:03.000Z","date":"2023-10-20","kind":"other","planned":false,"acquired":true,"shares":299402,"price":0.71,"value":212575.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised vested Warrants (the \"Original Warrants\") to purchase 299,402 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 (\"Closing Date\").  The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants."}],"balance_after":743804,"source":{"system":"sec-edgar","filing":"0001437749-23-028700","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923028700/rdgdoc.xml","form_type":"4"}},{"id":1915114,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-04-24T10:28:30.000Z","date":"2023-04-20","kind":"purchase","planned":false,"acquired":true,"shares":299402,"price":0.125,"value":37425.25,"ownership":{"direct":true},"balance_after":299402,"derivative":{"exercise_price":0.71,"exercise_date":"2023-04-20","expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":299402},"source":{"system":"sec-edgar","filing":"0001437749-23-010877","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923010877/rdgdoc.xml","form_type":"4"}},{"id":1915113,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-24T10:28:30.000Z","date":"2023-04-20","kind":"purchase","planned":false,"acquired":true,"shares":299402,"price":0.71,"value":212575.42,"ownership":{"direct":true},"balance_after":444402,"source":{"system":"sec-edgar","filing":"0001437749-23-010877","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923010877/rdgdoc.xml","form_type":"4"}},{"id":1961702,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-09T17:11:04.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":98706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four year period in equal monthly installments."}],"balance_after":98706,"derivative":{"exercise_price":1.28,"expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":98706},"source":{"system":"sec-edgar","filing":"0001437749-23-006007","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923006007/rdgdoc.xml","form_type":"4"}},{"id":2362481,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-02T16:32:40.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":74907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four year period in equal monthly installments."}],"balance_after":74907,"derivative":{"exercise_price":3.26,"expiration_date":"2032-02-28","underlying":"Common Stock","underlying_shares":74907},"source":{"system":"sec-edgar","filing":"0001437749-22-005023","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774922005023/rdgdoc.xml","form_type":"4"}},{"id":2410567,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-07T15:50:20.000Z","date":"2022-02-07","kind":"purchase","acquired":true,"shares":10334,"price":3.58,"value":36995.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.50 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges."}],"balance_after":145000,"source":{"system":"sec-edgar","filing":"0001437749-22-002613","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774922002613/rdgdoc.xml","form_type":"4"}},{"id":2432915,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-19T14:59:36.000Z","date":"2022-01-19","kind":"purchase","acquired":true,"shares":5000,"price":3.89,"value":19450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.87 to $3.89, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges."}],"balance_after":134666,"source":{"system":"sec-edgar","filing":"0001437749-22-001188","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774922001188/rdgdoc.xml","form_type":"4"}},{"id":2472221,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-15T11:19:57.000Z","date":"2021-12-15","kind":"purchase","acquired":true,"shares":5000,"price":3.89,"value":19450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.869 to $3.89, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges."}],"balance_after":129666,"source":{"system":"sec-edgar","filing":"0001437749-21-028622","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921028622/rdgdoc.xml","form_type":"4"}},{"id":2489589,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-02T16:34:26.000Z","date":"2021-12-02","kind":"purchase","acquired":true,"shares":5000,"price":4.93,"value":24650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $4.915 to $4.96, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges."}],"balance_after":124666,"source":{"system":"sec-edgar","filing":"0001437749-21-027709","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921027709/rdgdoc.xml","form_type":"4"}},{"id":2503575,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-19T13:05:55.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":5000,"price":5.25,"value":26250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $5.21 to $5.28, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges."}],"balance_after":119666,"source":{"system":"sec-edgar","filing":"0001437749-21-027140","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921027140/rdgdoc.xml","form_type":"4"}},{"id":2569991,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-15T15:39:25.000Z","date":"2021-09-15","kind":"purchase","acquired":true,"shares":5000,"price":6.35,"value":31750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $6.29 to $6.38, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges."}],"balance_after":114666,"source":{"system":"sec-edgar","filing":"0001437749-21-022183","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921022183/rdgdoc.xml","form_type":"4"}},{"id":2587186,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2021-08-30T19:02:36.000Z","date":"2021-08-27","kind":"grant","acquired":true,"shares":57300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four year period in equal monthly installments."}],"balance_after":57300,"derivative":{"exercise_price":7.46,"expiration_date":"2031-08-27","underlying":"Common Stock","underlying_shares":57300},"source":{"system":"sec-edgar","filing":"0001437749-21-021207","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921021207/rdgdoc.xml","form_type":"4"}},{"id":2898131,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-25T20:01:57.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":109666,"source":{"system":"sec-edgar","filing":"0001437749-21-001216","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774921001216/rdgdoc.xml","form_type":"4"}},{"id":2947293,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2020-12-14T16:02:24.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 20,000 \"Units\" purchased by the reporting person for $5.00 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":20000,"derivative":{"exercise_price":5,"exercise_date":"2020-12-11","expiration_date":"2025-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-20-025282","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920025282/rdgdoc.xml","form_type":"4"}},{"id":2947292,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-14T16:02:24.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 20,000 \"Units\" purchased by the reporting person for $5.00 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":99666,"source":{"system":"sec-edgar","filing":"0001437749-20-025282","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920025282/rdgdoc.xml","form_type":"4"}},{"id":3044897,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2020-08-28T16:06:11.000Z","date":"2020-08-27","kind":"purchase","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 500,000 \"Units\" purchased by the reporting person for $0.10 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":500000,"derivative":{"exercise_price":0.15,"exercise_date":"2020-08-27","expiration_date":"2027-08-27","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001437749-20-018939","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920018939/rdgdoc.xml","form_type":"4"}},{"id":3044896,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-28T16:06:11.000Z","date":"2020-08-27","kind":"purchase","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 500,000 \"Units\" purchased by the reporting person for $0.10 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":7966513,"source":{"system":"sec-edgar","filing":"0001437749-20-018939","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920018939/rdgdoc.xml","form_type":"4"}},{"id":3169475,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-04-27T16:07:17.000Z","date":"2020-04-24","kind":"purchase","acquired":true,"shares":730030,"price":0.1,"value":73003.0,"ownership":{"direct":true},"balance_after":7466513,"source":{"system":"sec-edgar","filing":"0001437749-20-008579","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774920008579/rdgdoc.xml","form_type":"4"}},{"id":3410143,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-19T13:27:19.000Z","date":"2019-09-18","kind":"purchase","acquired":true,"shares":10000,"price":0.175,"value":1750.0,"ownership":{"direct":true},"balance_after":6736483,"source":{"system":"sec-edgar","filing":"0001437749-19-018690","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774919018690/rdgdoc.xml","form_type":"4"}},{"id":3452554,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-07-31T11:02:23.000Z","date":"2019-07-31","kind":"purchase","acquired":true,"shares":50000,"price":0.25,"value":12500.0,"ownership":{"direct":true},"balance_after":6726483,"source":{"system":"sec-edgar","filing":"0001437749-19-015006","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774919015006/rdgdoc.xml","form_type":"4"}},{"id":3505469,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2019-06-03T14:34:43.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 400,000 \"Units\" purchased by the reporting person for $0.25 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":400000,"derivative":{"exercise_price":0.3,"exercise_date":"2019-05-31","expiration_date":"2024-11-30","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-19-011245","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774919011245/rdgdoc.xml","form_type":"4"}},{"id":3505468,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-03T14:34:43.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 400,000 \"Units\" purchased by the reporting person for $0.25 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":6676483,"source":{"system":"sec-edgar","filing":"0001437749-19-011245","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774919011245/rdgdoc.xml","form_type":"4"}},{"id":3720071,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-12-26T18:38:35.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":230769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 230,769 \"Units\" purchased by the reporting person for $0.65 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":230769,"derivative":{"exercise_price":0.65,"exercise_date":"2018-12-21","expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":230769},"source":{"system":"sec-edgar","filing":"0001437749-18-022627","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918022627/rdgdoc.xml","form_type":"4"}},{"id":3720070,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-12-26T18:38:35.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":230769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 230,769 \"Units\" purchased by the reporting person for $0.65 per Unit.  Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock."}],"balance_after":6276483,"source":{"system":"sec-edgar","filing":"0001437749-18-022627","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918022627/rdgdoc.xml","form_type":"4"}},{"id":3881675,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-06-28T16:04:07.000Z","date":"2018-05-23","kind":"exercise","acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the automatic conversion of Series B Convertible Preferred Stock (\"Series B Preferred\") into Common Stock upon the filing of Articles of Amendment to the Issuer's Articles of Incorporation increasing the Issuer's authorized shares of Common Stock.  The conversion is an exempt transaction pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred were included in \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consisted of one share of Series B Preferred convertible into 400 shares of Common Stock and one warrant to purchase 400 shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the automatic conversion of Series B Convertible Preferred Stock (\"Series B Preferred\") into Common Stock upon the filing of Articles of Amendment to the Issuer's Articles of Incorporation increasing the Issuer's authorized shares of Common Stock.  The conversion is an exempt transaction pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects the automatic conversion of Series B Convertible Preferred Stock (\"Series B Preferred\") into Common Stock upon the filing of Articles of Amendment to the Issuer's Articles of Incorporation increasing the Issuer's authorized shares of Common Stock.  The conversion is an exempt transaction pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Reflects the conversion of 1,000 shares of Series B Preferred held by the pension plan of a limited liability company of which the reporting person is the sole member, into 400,000 shares of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":0.25,"underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001437749-18-012620","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918012620/rdgdoc.xml","form_type":"4"}},{"id":3881674,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-06-28T16:04:07.000Z","date":"2018-05-23","kind":"exercise","acquired":true,"shares":800000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the automatic conversion of Series B Convertible Preferred Stock (\"Series B Preferred\") into Common Stock upon the filing of Articles of Amendment to the Issuer's Articles of Incorporation increasing the Issuer's authorized shares of Common Stock.  The conversion is an exempt transaction pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred were included in \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consisted of one share of Series B Preferred convertible into 400 shares of Common Stock and one warrant to purchase 400 shares of Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Reflects the conversion of 1,000 shares of Series B Preferred held by the pension plan of a limited liability company of which the reporting person is the sole member, into 400,000 shares of Common Stock."}],"balance_after":6045714,"source":{"system":"sec-edgar","filing":"0001437749-18-012620","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918012620/rdgdoc.xml","form_type":"4"}},{"id":3957438,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-04-25T16:02:19.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of 1,000 \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consists of one share of Series B Preferred and warrants to purchase 400 shares of Common Stock."}],"balance_after":400000,"derivative":{"exercise_price":0.25,"exercise_date":"2018-04-23","expiration_date":"2025-04-23","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-18-007687","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918007687/rdgdoc.xml","form_type":"4"}},{"id":3957437,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-04-25T16:02:19.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of 1,000 \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consists of one share of Series B Preferred and warrants to purchase 400 shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Convertible Preferred Stock (\"Series B Preferred\") will automatically convert into Common Stock on the date the Issuer effects an increase of its authorized shares of Common Stock and/or a reverse stock split so that it has a sufficient number of authorized and unissued shares of Common Stock to permit the conversion or exercise, as applicable of all outstanding shares of Series B Preferred, warrants, options and other convertible securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Convertible Preferred Stock (\"Series B Preferred\") will automatically convert into Common Stock on the date the Issuer effects an increase of its authorized shares of Common Stock and/or a reverse stock split so that it has a sufficient number of authorized and unissued shares of Common Stock to permit the conversion or exercise, as applicable of all outstanding shares of Series B Preferred, warrants, options and other convertible securities of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Includes 1,000 shares of Series B Preferred held by the pension plan of a limited liability company of which the reporting person is the sole member."}],"balance_after":2000,"derivative":{"exercise_price":0.25,"underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-18-007687","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918007687/rdgdoc.xml","form_type":"4"}},{"id":4077321,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-02-05T16:27:42.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5245714,"source":{"system":"sec-edgar","filing":"0001437749-18-001673","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774918001673/rdgdoc.xml","form_type":"4"}},{"id":4183230,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-10-19T16:01:55.000Z","date":"2017-10-18","kind":"purchase","acquired":true,"shares":400000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of 1,000 \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consists of one share of Series B Preferred and warrants to purchase 400 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Units were purchased by the pension plan of a limited liability company of which the reporting person is the sole member."}],"balance_after":400000,"derivative":{"exercise_price":0.25,"exercise_date":"2017-10-18","expiration_date":"2024-10-18","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-17-017327","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774917017327/rdgdoc.xml","form_type":"4"}},{"id":4183229,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2017-10-19T16:01:55.000Z","date":"2017-10-18","kind":"purchase","acquired":true,"shares":1000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of 1,000 \"Units\" purchased by the reporting person for $100 per Unit.  Each Unit consists of one share of Series B Preferred and warrants to purchase 400 shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Convertible Preferred Stock (\"Series B Preferred\") will automatically convert into Common Stock on the date the Issuer effects an increase of its authorized shares of Common Stock and/or a reverse stock split so that it has a sufficient number of authorized and unissued shares of Common Stock to permit the conversion or exercise, as applicable of all outstanding shares of Series B Preferred, warrants, options and other convertible securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Convertible Preferred Stock (\"Series B Preferred\") will automatically convert into Common Stock on the date the Issuer effects an increase of its authorized shares of Common Stock and/or a reverse stock split so that it has a sufficient number of authorized and unissued shares of Common Stock to permit the conversion or exercise, as applicable of all outstanding shares of Series B Preferred, warrants, options and other convertible securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Units were purchased by the pension plan of a limited liability company of which the reporting person is the sole member."}],"balance_after":1000,"derivative":{"exercise_price":0.25,"underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-17-017327","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774917017327/rdgdoc.xml","form_type":"4"}},{"id":4268082,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-07-03T16:03:23.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5225714,"source":{"system":"sec-edgar","filing":"0001213900-17-007096","document":"f4063017fine_ctdholdings.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000121390017007096/f4063017fine_ctdholdings.xml","form_type":"4"}},{"id":4284912,"issuer":{"id":5540,"kind":"organization","name":"Forward Industries, Inc.","symbol":"FWDI"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-13T20:00:58.000Z","date":"2017-06-10","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0001003297-17-000184","document":"fine.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/38264/000100329717000184/fine.xml","form_type":"4"}},{"id":4362880,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-04T16:06:21.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5205714,"source":{"system":"sec-edgar","filing":"0001213900-17-003310","document":"f4033117fine_ctdholdings.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000121390017003310/f4033117fine_ctdholdings.xml","form_type":"4"}},{"id":4422653,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-02-27T12:15:18.000Z","date":"2017-02-23","kind":"purchase","acquired":true,"shares":285714,"ownership":{"direct":false,"nature":"footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 285,714 \"Units\" purchased by the reporting person for $0.35 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Units were purchased by a limited liability company of which the reporting person is the sole member."}],"balance_after":285714,"derivative":{"exercise_price":0.35,"exercise_date":"2017-02-23","expiration_date":"2024-02-23","underlying":"Common Stock","underlying_shares":285714},"source":{"system":"sec-edgar","filing":"0001213900-17-001791","document":"f4022317fine_ctdholding.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000121390017001791/f4022317fine_ctdholding.xml","form_type":"4"}},{"id":4422652,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-27T12:15:18.000Z","date":"2017-02-23","kind":"purchase","acquired":true,"shares":285714,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of 285,714 \"Units\" purchased by the reporting person for $0.35 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Units were purchased by a limited liability company of which the reporting person is the sole member."}],"balance_after":5185714,"source":{"system":"sec-edgar","filing":"0001213900-17-001791","document":"f4022317fine_ctdholding.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000121390017001791/f4022317fine_ctdholding.xml","form_type":"4"}},{"id":4592470,"issuer":{"id":5540,"kind":"organization","name":"Forward Industries, Inc.","symbol":"FWDI"},"owners":[{"id":30602,"kind":"person","name":"FINE N SCOTT","position":1,"cik":"0001163556","reported_name":"FINE N SCOTT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-30T20:08:17.000Z","date":"2016-02-23","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001003297-16-000837","document":"fine.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/38264/000100329716000837/fine.xml","form_type":"4"}}]}